Advancing Flow Chemistry in API Manufacturing - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Advancing Flow Chemistry in API Manufacturing
Continuous flow chemistry offers potential for greater control, improved safety and environmental profiles, and efficient chemical transformations.


Pharmaceutical Technology
Volume 37, Issue 4, pp. 78-82

References

1. P. Van Arnum, Pharm. Technol. (36), 7, 50 (2012).

2. J. Hamby, “API Synthesis, Formulation Development, and Manufacturing” supplement to Pharm. Technol. 34, s18–19 (2010).

3. N. Korman et al., “API Synthesis, Formulation Development, and Manufacturing” supplement to Pharm. Technol. 34 , s32–s36 (2010).

4. P. Van Arnum, Pharm. Technol. 35 (8), 52–56 (2011).

5. S.A. May et al., Org. Process Res. Dev. 16 (5), 982-1002 (2012).

6. M.D. Johnson et al., Org. Process Res. Dev. 16 (5), 1017-1038 (2012).

7. S.Y. Wong et al., Org. Process Res. Dev. , online, DOI: 10.1021/op400011s, Mar.17, 2013.

8. T. Noel et al., Agnew. Chem. Int. Ed. online, DOI: 10.1002/anie.201101480, 17 May 2011.

9. S.R. Ritter, Chem. & Eng. News 89 (23), 39 (2011).

10. C. Crosjean et al., Org. Process Res. Dev. 16 (5), 781-787 (2012).

11. T. Tsubugo, Y. Yamashita, and S. Kobayashi et al., Chem. Eur. J. 18 (43), 13624-13628 (2012).

12. T. N. Glasnov, J. Flow Chem. 3 (4), 135-141 (2012).

13. A. Nagaki et al., Chem. Eur. J. 18 (38), 11871-11875 (2012).

14. K. Terao et al., J. Flow Chem. 2 (3), 73-76 (2012).

15.M. Rueping, T. Bootwicha, and E. Sugiono, Beilstein J. Org. Chem. 8, 300-307 (2012).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
28%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
9%
All of the above.
45%
No government involvement in patient treatment or drug development.
7%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
Source: Pharmaceutical Technology,
Click here